493 related articles for article (PubMed ID: 34238294)
1. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.
Zhu Y; Liu K; Chen M; Liu Y; Gao A; Hu C; Li H; Zhu H; Han H; Zhang J; Zhao Y
Cardiovasc Diabetol; 2021 Jul; 20(1):137. PubMed ID: 34238294
[TBL] [Abstract][Full Text] [Related]
2. The association between the triglyceride-glucose index and in-stent restenosis in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Jiang H; Liu Y; Guo H; Liu Z; Li Z
BMC Cardiovasc Disord; 2024 May; 24(1):234. PubMed ID: 38702615
[TBL] [Abstract][Full Text] [Related]
3. Systemic immune-inflammation index and in-stent restenosis in patients with acute coronary syndrome: a single-center retrospective study.
Xie F; Yu Z; Xiong Y; Wu Z; Wu Y
Eur J Med Res; 2024 Feb; 29(1):145. PubMed ID: 38409069
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance, coronary artery lesion complexity and adverse cardiovascular outcomes in patients with acute coronary syndrome.
Chen Q; Xiong S; Ye T; Gao Y; Wang J; Li X; Li Y; Cui C; Liu H; Zhang Z; Cai L; Zheng J
Cardiovasc Diabetol; 2024 May; 23(1):172. PubMed ID: 38755609
[TBL] [Abstract][Full Text] [Related]
5. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
Zhao LP; Xu WT; Wang L; Li H; Shao CL; Gu HB; Chan SP; Xu HF; Yang XJ
Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654
[TBL] [Abstract][Full Text] [Related]
6. High triglyceride-glucose index is associated with poor cardiovascular outcomes in Chinese acute coronary syndrome patients without diabetes mellitus who underwent emergency percutaneous coronary intervention with drug-eluting stents.
Zhang Y; Chu C; Zhong Z; Luo YB; Ning FF; Guo N
Front Endocrinol (Lausanne); 2023; 14():1101952. PubMed ID: 36875470
[TBL] [Abstract][Full Text] [Related]
7. Triglyceride-glucose index is associated with recurrent revascularization in patients with type 2 diabetes mellitus after percutaneous coronary intervention.
Chen Q; Xiong S; Zhang Z; Yu X; Chen Y; Ye T; Yang S; Qi L; Chen X; Liu H; Zheng J; Cai L
Cardiovasc Diabetol; 2023 Oct; 22(1):284. PubMed ID: 37865753
[TBL] [Abstract][Full Text] [Related]
8. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.
Luo E; Wang D; Yan G; Qiao Y; Liu B; Hou J; Tang C
Cardiovasc Diabetol; 2019 Nov; 18(1):150. PubMed ID: 31722708
[TBL] [Abstract][Full Text] [Related]
9. Serum glycated albumin is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents: An observational study.
Lin XL; Li QY; Zhao DH; Liu JH; Fan Q
Front Cardiovasc Med; 2022; 9():943185. PubMed ID: 36237913
[TBL] [Abstract][Full Text] [Related]
10. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.
Qin Z; Zhou K; Li YP; Wang JL; Cheng WJ; Hu CP; Shi C; He H; Zhou YJ
Cardiovasc Diabetol; 2019 Jan; 18(1):11. PubMed ID: 30691501
[TBL] [Abstract][Full Text] [Related]
11. Association between the triglyceride-glucose index and in-hospital major adverse cardiovascular events in patients with acute coronary syndrome: results from the Improving Care for Cardiovascular Disease in China (CCC)-Acute Coronary Syndrome project.
Wang W; Yang J; Wang K; Niu J; Liu Y; Ge H;
Cardiovasc Diabetol; 2024 May; 23(1):170. PubMed ID: 38750553
[TBL] [Abstract][Full Text] [Related]
12. Acute coronary syndrome - a frequent clinical manifestation of bare metal in-stent restenosis.
Drozd J; Wójcik J; Małek R; Korona B; Zapolski T; Wysokiński A
Kardiol Pol; 2010 Jun; 68(6):637-45. PubMed ID: 20806192
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.
Magalhaes MA; Minha S; Chen F; Torguson R; Omar AF; Loh JP; Escarcega RO; Lipinski MJ; Baker NC; Kitabata H; Ota H; Suddath WO; Satler LF; Pichard AD; Waksman R
Circ Cardiovasc Interv; 2014 Dec; 7(6):768-76. PubMed ID: 25466551
[TBL] [Abstract][Full Text] [Related]
14. Systemic immune inflammation index and its implication on in-stent restenosis among patients with acute coronary syndrome.
Ösken A; Polat F; Çakir B; Zengin A; Çalik AN; Ünal Dayi Ş; Çam N
Coron Artery Dis; 2024 May; 35(3):209-214. PubMed ID: 38180335
[TBL] [Abstract][Full Text] [Related]
15. Association of the triglyceride glucose-body mass index with the extent of coronary artery disease in patients with acute coronary syndromes.
Yang X; Li K; Wen J; Yang C; Li Y; Xu G; Ma Y
Cardiovasc Diabetol; 2024 Jan; 23(1):24. PubMed ID: 38218893
[TBL] [Abstract][Full Text] [Related]
16. Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention.
Dong S; Zhao Z; Huang X; Ma M; Yang Z; Fan C; Han H; Wang Z; Shi D; Zhou Y
Cardiovasc Diabetol; 2023 Oct; 22(1):286. PubMed ID: 37891647
[TBL] [Abstract][Full Text] [Related]
17. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.
Rathore S; Kinoshita Y; Terashima M; Katoh O; Matsuo H; Tanaka N; Kimura M; Tsuchikane E; Nasu K; Ehara M; Asakura K; Asakura Y; Suzuki T
EuroIntervention; 2010 Feb; 5(7):841-6. PubMed ID: 20142201
[TBL] [Abstract][Full Text] [Related]
18. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
Zhao K; Li YJ; Gao S
Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
[TBL] [Abstract][Full Text] [Related]
19. Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry.
Lee JM; Rhee TM; Hahn JY; Hwang D; Park J; Park KW; Kim HL; Kim SH; Chae IH; Doh JH; Jeon KH; Choi YJ; Park JS; Choi SH; Gwon HC; Koo BK; Alfonso F; Kim HS
Int J Cardiol; 2017 Mar; 230():181-190. PubMed ID: 28043660
[TBL] [Abstract][Full Text] [Related]
20. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Melgares R; Mainar V; Moreno R; Domínguez A; Sanchís J; Bethencourt A; Moreu J; Cequier A; Martí V; Otaegui I; Bastante T; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C;
Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]